Tuesday, September 30, 2014 8:59:57 PM
Hemispherx's Two Experimental Therapeutics May Provide Benefit Despite Recently Discovered Ebola Viral Mutations / Sept. 29, 2014
http://finance.yahoo.com/news/hemispherx-biopharma-expands-research-potential-123000003.html
HEB made a giant move in AH's trading on Tuesday............HEB should open tomorrow above the upper trend line on the FINVIZ.com chart & should be trading above the 200 DMA @ 0.338............$$$
http://finviz.com/quote.ashx?t=Heb&ty=c&ta=1&p=d
Learn how to analyze Charts & interpret Japanese candlestick patterns........link below...........$$$
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86130044
Recent HEB News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
